. | Variable . | Odds ratio . | Lower CI . | Upper CI . | P value . |
---|---|---|---|---|---|
1 | CHADSVASC | 1.715 | 1.083 | 2.716 | 0.0214 |
2 | EF | 0.902 | 0.820 | 0.992 | 0.0331 |
3 | Age | 1.119 | 1.001 | 1.252 | 0.0473 |
4 | Female | 2.885 | 0.747 | 11.138 | 0.1243 |
5 | HTN | 5.250 | 0.631 | 43.646 | 0.1249 |
6 | ACTMAX | 1.014 | 0.996 | 1.033 | 0.1296 |
7 | DAYPROCMR | 1.559 | 0.866 | 2.804 | 0.1386 |
8 | CAD | 3.551 | 0.590 | 21.381 | 0.1665 |
9 | CHADS | 1.558 | 0.825 | 2.939 | 0.1714 |
10 | RF | 2.148 | 0.545 | 8.464 | 0.2744 |
11 | FLUORO | 0.963 | 0.856 | 1.084 | 0.5340 |
12 | ACT250 | 0.651 | 0.168 | 2.527 | 0.5350 |
13 | ACTLOW | 1.004 | 0.989 | 1.019 | 0.5797 |
14 | PAF | 0.672 | 0.157 | 2.884 | 0.5931 |
15 | PREPROCIN | 1.330 | 0.460 | 3.843 | 0.5981 |
16 | AAD | 0.677 | 0.127 | 3.618 | 0.6482 |
17 | ACT300 | 0.806 | 0.157 | 4.141 | 0.7958 |
18 | LA | 0.983 | 0.863 | 1.121 | 0.8032 |
19 | Stroke | 1.297 | 0.140 | 12.030 | 0.8193 |
20 | CV | 1.122 | 0.265 | 4.751 | 0.8753 |
21 | PERSIST | 1.083 | 0.243 | 4.827 | 0.9164 |
22 | DM | 1.095 | 0.120 | 9.958 | 0.9356 |
23 | LASER | 0.949 | 0.254 | 3.547 | 0.9376 |
24 | PROCTIME | 1.000 | 0.988 | 1.013 | 0.9439 |
. | Variable . | Odds ratio . | Lower CI . | Upper CI . | P value . |
---|---|---|---|---|---|
1 | CHADSVASC | 1.715 | 1.083 | 2.716 | 0.0214 |
2 | EF | 0.902 | 0.820 | 0.992 | 0.0331 |
3 | Age | 1.119 | 1.001 | 1.252 | 0.0473 |
4 | Female | 2.885 | 0.747 | 11.138 | 0.1243 |
5 | HTN | 5.250 | 0.631 | 43.646 | 0.1249 |
6 | ACTMAX | 1.014 | 0.996 | 1.033 | 0.1296 |
7 | DAYPROCMR | 1.559 | 0.866 | 2.804 | 0.1386 |
8 | CAD | 3.551 | 0.590 | 21.381 | 0.1665 |
9 | CHADS | 1.558 | 0.825 | 2.939 | 0.1714 |
10 | RF | 2.148 | 0.545 | 8.464 | 0.2744 |
11 | FLUORO | 0.963 | 0.856 | 1.084 | 0.5340 |
12 | ACT250 | 0.651 | 0.168 | 2.527 | 0.5350 |
13 | ACTLOW | 1.004 | 0.989 | 1.019 | 0.5797 |
14 | PAF | 0.672 | 0.157 | 2.884 | 0.5931 |
15 | PREPROCIN | 1.330 | 0.460 | 3.843 | 0.5981 |
16 | AAD | 0.677 | 0.127 | 3.618 | 0.6482 |
17 | ACT300 | 0.806 | 0.157 | 4.141 | 0.7958 |
18 | LA | 0.983 | 0.863 | 1.121 | 0.8032 |
19 | Stroke | 1.297 | 0.140 | 12.030 | 0.8193 |
20 | CV | 1.122 | 0.265 | 4.751 | 0.8753 |
21 | PERSIST | 1.083 | 0.243 | 4.827 | 0.9164 |
22 | DM | 1.095 | 0.120 | 9.958 | 0.9356 |
23 | LASER | 0.949 | 0.254 | 3.547 | 0.9376 |
24 | PROCTIME | 1.000 | 0.988 | 1.013 | 0.9439 |
CI, confidence interval; CHADASVASC, CHA2DS2VASc score; EF, ejection fraction; HTN, hypertension; ACTMAX, maximum ACT; DAYPROCMRI, days between procedure and post-procedural MRI; CAD, coronary artery disease; CHADS, CHADS2 score; RF, radiofrequency; FLURO, fluoroscopy; ACT250, ACT value <250; ACTLOW, lowest ACT value; PAF, paroxysmal atrial fibrillation; PREPROCINR, pre-procedural INR; AAD, antiarrhythmic drug; ACT300, ACT value <300; LA, left atrium; CV, electrical cardioversion; PERSIST, persistent atrial fibrillation; DM, diabetes mellitus; LASER, laserballoon; PROCTIME, procedure time.
. | Variable . | Odds ratio . | Lower CI . | Upper CI . | P value . |
---|---|---|---|---|---|
1 | CHADSVASC | 1.715 | 1.083 | 2.716 | 0.0214 |
2 | EF | 0.902 | 0.820 | 0.992 | 0.0331 |
3 | Age | 1.119 | 1.001 | 1.252 | 0.0473 |
4 | Female | 2.885 | 0.747 | 11.138 | 0.1243 |
5 | HTN | 5.250 | 0.631 | 43.646 | 0.1249 |
6 | ACTMAX | 1.014 | 0.996 | 1.033 | 0.1296 |
7 | DAYPROCMR | 1.559 | 0.866 | 2.804 | 0.1386 |
8 | CAD | 3.551 | 0.590 | 21.381 | 0.1665 |
9 | CHADS | 1.558 | 0.825 | 2.939 | 0.1714 |
10 | RF | 2.148 | 0.545 | 8.464 | 0.2744 |
11 | FLUORO | 0.963 | 0.856 | 1.084 | 0.5340 |
12 | ACT250 | 0.651 | 0.168 | 2.527 | 0.5350 |
13 | ACTLOW | 1.004 | 0.989 | 1.019 | 0.5797 |
14 | PAF | 0.672 | 0.157 | 2.884 | 0.5931 |
15 | PREPROCIN | 1.330 | 0.460 | 3.843 | 0.5981 |
16 | AAD | 0.677 | 0.127 | 3.618 | 0.6482 |
17 | ACT300 | 0.806 | 0.157 | 4.141 | 0.7958 |
18 | LA | 0.983 | 0.863 | 1.121 | 0.8032 |
19 | Stroke | 1.297 | 0.140 | 12.030 | 0.8193 |
20 | CV | 1.122 | 0.265 | 4.751 | 0.8753 |
21 | PERSIST | 1.083 | 0.243 | 4.827 | 0.9164 |
22 | DM | 1.095 | 0.120 | 9.958 | 0.9356 |
23 | LASER | 0.949 | 0.254 | 3.547 | 0.9376 |
24 | PROCTIME | 1.000 | 0.988 | 1.013 | 0.9439 |
. | Variable . | Odds ratio . | Lower CI . | Upper CI . | P value . |
---|---|---|---|---|---|
1 | CHADSVASC | 1.715 | 1.083 | 2.716 | 0.0214 |
2 | EF | 0.902 | 0.820 | 0.992 | 0.0331 |
3 | Age | 1.119 | 1.001 | 1.252 | 0.0473 |
4 | Female | 2.885 | 0.747 | 11.138 | 0.1243 |
5 | HTN | 5.250 | 0.631 | 43.646 | 0.1249 |
6 | ACTMAX | 1.014 | 0.996 | 1.033 | 0.1296 |
7 | DAYPROCMR | 1.559 | 0.866 | 2.804 | 0.1386 |
8 | CAD | 3.551 | 0.590 | 21.381 | 0.1665 |
9 | CHADS | 1.558 | 0.825 | 2.939 | 0.1714 |
10 | RF | 2.148 | 0.545 | 8.464 | 0.2744 |
11 | FLUORO | 0.963 | 0.856 | 1.084 | 0.5340 |
12 | ACT250 | 0.651 | 0.168 | 2.527 | 0.5350 |
13 | ACTLOW | 1.004 | 0.989 | 1.019 | 0.5797 |
14 | PAF | 0.672 | 0.157 | 2.884 | 0.5931 |
15 | PREPROCIN | 1.330 | 0.460 | 3.843 | 0.5981 |
16 | AAD | 0.677 | 0.127 | 3.618 | 0.6482 |
17 | ACT300 | 0.806 | 0.157 | 4.141 | 0.7958 |
18 | LA | 0.983 | 0.863 | 1.121 | 0.8032 |
19 | Stroke | 1.297 | 0.140 | 12.030 | 0.8193 |
20 | CV | 1.122 | 0.265 | 4.751 | 0.8753 |
21 | PERSIST | 1.083 | 0.243 | 4.827 | 0.9164 |
22 | DM | 1.095 | 0.120 | 9.958 | 0.9356 |
23 | LASER | 0.949 | 0.254 | 3.547 | 0.9376 |
24 | PROCTIME | 1.000 | 0.988 | 1.013 | 0.9439 |
CI, confidence interval; CHADASVASC, CHA2DS2VASc score; EF, ejection fraction; HTN, hypertension; ACTMAX, maximum ACT; DAYPROCMRI, days between procedure and post-procedural MRI; CAD, coronary artery disease; CHADS, CHADS2 score; RF, radiofrequency; FLURO, fluoroscopy; ACT250, ACT value <250; ACTLOW, lowest ACT value; PAF, paroxysmal atrial fibrillation; PREPROCINR, pre-procedural INR; AAD, antiarrhythmic drug; ACT300, ACT value <300; LA, left atrium; CV, electrical cardioversion; PERSIST, persistent atrial fibrillation; DM, diabetes mellitus; LASER, laserballoon; PROCTIME, procedure time.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.